Animal Models for Yersinia pestis

  • Yujing Bi
  • Xiaoyi Wang
Part of the Springer Protocols Handbooks book series (SPH)


Many animal models have now been developed to mimic the course of Yersinia pestis infection. These models are useful for understanding, defending against, and treating plague. Studies have indicated that rodent and nonhuman primate models of pneumonic plague closely resemble human disease, and pathologic changes that occur in rodents, nonhuman primates, and humans during bubonic plague are very similar. Thus, classic model organisms, such as mouse and monkey, are still widely used for different purposes. This section describes Y. pestis infection in mouse via subcutaneous, intravenous, intraperitoneal, and intranasal routes or in monkeys via subcutaneous and intravenous routes. The protocols described in this chapter require special handling conditions for infected animals, and very close attention should be given to the specific recommendations for animal care with each infectious agent.

Key words

Yersinia pestis Animal model Mouse Monkey 


  1. 1.
    Perry RD, Fetherston JD (1997) Yersinia pestis – etiologic agent of plague. Clin Microbiol Rev 10(1):35–66PubMedPubMedCentralGoogle Scholar
  2. 2.
    Meyer KF (1961) Pneumonic plague. Bacteriol Rev 25:249–261PubMedPubMedCentralGoogle Scholar
  3. 3.
    Chen TH, Meyer KF (1974) Susceptibility and antibody response of Rattus species to experimental plague. J Infect Dis 129(Suppl):S62–S71CrossRefGoogle Scholar
  4. 4.
    Jones SM, Day F, Stagg AJ, Williamson ED (2000) Protection conferred by a fully recombinant sub-unit vaccine against Yersinia pestis in male and female mice of four inbred strains. Vaccine 19(2–3):358–366CrossRefPubMedGoogle Scholar
  5. 5.
    Elvin SJ, Williamson ED (2004) Stat 4 but not Stat 6 mediated immune mechanisms are essential in protection against plague. Microb Pathog 37(4):177–184CrossRefPubMedGoogle Scholar
  6. 6.
    Grosfeld H, Cohen S, Bino T, Flashner Y, Ber R, Mamroud E, Kronman C, Shafferman A, Velan B (2003) Effective protective immunity to Yersinia pestis infection conferred by DNA vaccine coding for derivatives of the F1 capsular antigen. Infect Immun 71(1):374–383CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Garmory HS, Freeman D, Brown KA, Titball RW (2004) Protection against plague afforded by immunisation with DNA vaccines optimised for expression of the Yersinia pestis V antigen. Vaccine 22(8):947–957CrossRefPubMedGoogle Scholar
  8. 8.
    Davis KJ, Fritz DL, Pitt ML, Welkos SL, Worsham PL, Friedlander AM (1996) Pathology of experimental pneumonic plague produced by fraction 1-positive and fraction 1-negative Yersinia pestis in African green monkeys (Cercopithecus aethiops). Arch Pathol Lab Med 120(2):156–163PubMedGoogle Scholar
  9. 9.
    Oyston PC, Russell P, Williamson ED, Titball RW (1996) An aroA mutant of Yersinia pestis is attenuated in guinea-pigs, but virulent in mice. Microbiology 142(Pt 7):1847–1853CrossRefPubMedGoogle Scholar
  10. 10.
    Smiley ST (2008) Current challenges in the development of vaccines for pneumonic plague. Expert Rev Vaccines 7(2):209–221CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Cornelius CA, Quenee LE, Overheim KA, Koster F, Brasel TL, Elli D, Ciletti NA, Schneewind O (2008) Immunization with recombinant V10 protects cynomolgus macaques from lethal pneumonic plague. Infect Immun 76(12):5588–5597CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Van Andel R, Sherwood R, Gennings C, Lyons CR, Hutt J, Gigliotti A, Barr E (2008) Clinical and pathologic features of cynomolgus macaques (Macaca fascicularis) infected with aerosolized Yersinia pestis. Comp Med 58(1):68–75PubMedPubMedCentralGoogle Scholar
  13. 13.
    Koster F, Perlin DS, Park S, Brasel T, Gigliotti A, Barr E, Myers L, Layton RC, Sherwood R, Lyons CR (2010) Milestones in progression of primary pneumonic plague in cynomolgus macaques. Infect Immun 78(7):2946–2955CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Tian G, Qiu Y, Qi Z, Wu X, Zhang Q, Bi Y, Yang Y, Li Y, Yang X, Xin Y et al (2011) Histopathological observation of immunized rhesus macaques with plague vaccines after subcutaneous infection of Yersinia pestis. PLoS One 6(4):e19260CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Zhang Q, Wang Q, Tian G, Qi Z, Zhang X, Wu X, Qiu Y, Bi Y, Yang X, Xin Y et al (2014) Yersinia pestis biovar Microtus strain 201, an avirulent strain to humans, provides protection against bubonic plague in rhesus macaques. Hum Vaccin Immunother 10(2):1–10CrossRefGoogle Scholar
  16. 16.
    Tian G, Qi Z, Qiu Y, Wu X, Zhang Q, Yang X, Xin Y, He J, Bi Y, Wang Q et al (2015) Comparison of virulence between the Yersinia pestis Microtus 201, an avirulent strain to humans, and the vaccine strain EV in rhesus macaques, Macaca mulatta. Hum Vaccin Immunother 10(12):3552–3560CrossRefGoogle Scholar
  17. 17.
    Wang X, Zhang X, Zhou D, Yang R (2013) Live-attenuated Yersinia pestis vaccines. Expert Rev Vaccines 12(6):677–686CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2018

Authors and Affiliations

  • Yujing Bi
    • 1
  • Xiaoyi Wang
    • 1
  1. 1.Beijing Institute of Microbiology and EpidemiologyBeijingChina

Personalised recommendations